LAMEA Herpes Simplex Virus Treatment Market

LAMEA Herpes Simplex Virus Treatment Market Size, Share & Industry Trends Analysis Report By Drug Type, By Type (Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection), By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-14464 Publication Date: March-2023 Number of Pages: 88
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Herpes Simplex Virus Treatment Market would witness market growth of 6.6% CAGR during the forecast period (2022-2028).

As HSV infection is more likely to reactivate in the first few months following solid organ and bone marrow transplants, the rise in the number of transplant recipients is a factor in the market's expansion. In accordance with this, researchers are concentrating on creating novel antiviral drugs to increase the range of available treatments for genital and orolabial herpes. Also, they are bringing out antiviral creams or ointments that can lessen HSV-related itching, burning, or tingling sensations, enhance the quality of life (QoL) of patients, and stop infected persons from transmitting the virus.

Many people have HSV that is asymptomatic, which means they carry the virus but have never experienced a herpes outbreak or active episode. Others may occasionally get sores or blisters that are tiny and filled with fluid. These blisters can appear on the hands, fingers, or other body parts but typically on the genitalia, mouth, or lips. The herpes virus can be spread through sexual contact, but other ways exist. Herpes carries a lot of stigmas, yet the virus is fairly widespread. As more people are becoming aware of this, the demand for HSV medication is rising.

Latin America has a high HSV-2 seroprevalence. An estimated 20% to 60% of people are infected. Middle-aged Colombian women were found to have the highest HSV-2 frequency in the region. In Brazil, women are more likely to contract HSV-2 if their male partners have a record of anal sex and have had numerous sexual partners during their lifetime. As a result, many regional governments have increased their efforts to mitigate the burden of the disease as well as increase the awareness about it among the general public. The government's provision of HSV treatment at affordable costs is among these efforts. Consequently, such efforts significantly boost the market expansion in this region.

The Brazil market dominated the LAMEA Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $47.6 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 6.3% during (2022 - 2028).

Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Herpes Simplex Virus Treatment Market is Projected to reach USD 2.1 Billion by 2028, at a CAGR of 3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

  • Valacyclovir
  • Acyclovir
  • Famciclovir

By Type

  • Herpes simplex virus-1 Infection
  • Herpes simplex virus-2 Infection

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Pfizer, Inc.
  • Amneal Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Glenmark Pharmaceuticals Limited
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Viatris, Inc.
  • Emcure Pharmaceuticals Limited
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo